BusinessInFocus Capital Partners Completes Series A Investment in Qura, Inc.By Nasdaq OMXJan 31, 2018, 1:03 PM UTC
BusinessAXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye IndicationsBy Nasdaq OMXMar 21, 2017, 1:01 PM UTC
BusinessAXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye IndicationsBy Nasdaq OMXMar 21, 2017, 1:01 PM UTC
BusinessAxim® Biotech Announces Addition of World-Renowned Opthamologist to Advisory BoardBy Nasdaq OMXDec 27, 2016, 2:00 PM UTC
